🇪🇺 Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) in European Union

Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) (tozinameran-bnt162b2-riltozinameran-bnt162b2-omi-ba-1) regulatory status in European Union.

Marketing authorisation

EMA

Status: approved

Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

🇨🇦 Canada
🇬🇧 United Kingdom
🇺🇸 United States

Other Immunology approved in European Union

Frequently asked questions

Is Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.